-
1
-
-
77955651626
-
Axillary lymph node involvement in women with breast cancer: Does it depend on age?
-
Botteri E, Bagnardi V, Goldhirsch A, et al. Axillary lymph node involvement in women with breast cancer: does it depend on age? Clin Breast Cancer 2010; 10:318-321
-
(2010)
Clin Breast Cancer
, vol.10
, pp. 318-321
-
-
Botteri, E.1
Bagnardi, V.2
Goldhirsch, A.3
-
2
-
-
0035845511
-
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
-
Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci\USA 2001; 98:10869-10874
-
(2001)
Proc Natl Acad Sci\USA
, vol.98
, pp. 10869-10874
-
-
Sørlie, T.1
Perou, C.M.2
Tibshirani, R.3
-
3
-
-
34247145491
-
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
-
[erratum published in: J Clin Oncol 2007; 25:3790]
-
Loi S, Haibe-Kains B, Desmedt C, et al. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade [erratum published in: J Clin Oncol 2007; 25:3790]. J Clin Oncol 2007; 25:1239-1246
-
(2007)
J Clin Oncol
, vol.25
, pp. 1239-1246
-
-
Loi, S.1
Haibe-Kains, B.2
Desmedt, C.3
-
4
-
-
19944422061
-
A multigene assay to predict recurrence of tamoxifen treated node negative breast cancer
-
Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen treated node negative breast cancer. N Engl J Med 2004; 351:2817-2826
-
(2004)
N Engl J Med
, vol.351
, pp. 2817-2826
-
-
Paik, S.1
Shak, S.2
Tang, G.3
-
5
-
-
0037137519
-
A gene-expression signature as a predictor of survival in breast cancer
-
van de Vijver MJ, He YD, van'tVeer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347:1999-2009.
-
(2002)
N Engl J Med
, vol.347
, pp. 1999-2009
-
-
Van De Vijver, M.J.1
He, Y.D.2
Van'T Veer, L.J.3
-
6
-
-
55249116037
-
Trial assessing individualized options for treatment for breast cancer: The TAILORx trial
-
Zujewski JA, Kamin L. Trial assessing individualized options for treatment for breast cancer: the TAILORx trial. Future Oncol 2008; 4:603-610
-
(2008)
Future Oncol
, vol.4
, pp. 603-610
-
-
Zujewski, J.A.1
Kamin, L.2
-
7
-
-
67650410053
-
MammaPrint 70-gene signature: Another milestone in personalized medical care for breast cancer patients
-
Slodkowska EA, Ross JS. MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients. Expert Rev Mol Diagn 2009; 9:417-422
-
(2009)
Expert Rev Mol Diagn
, vol.9
, pp. 417-422
-
-
Slodkowska, E.A.1
Ross, J.S.2
-
8
-
-
77955616317
-
ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node
-
(abstract CRA506)
-
Giuliano AE, McCall LM, Beitsch PD, et al. ACOSOG Z0011: a randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node. J Clin Oncol 2010; 28(15 suppl):69s (abstract CRA506).
-
(2010)
J Clin Oncol
, vol.28
, Issue.15 SUPPL.
-
-
Giuliano, A.E.1
McCall, L.M.2
Beitsch, P.D.3
-
9
-
-
77950512587
-
Breast cancer subtypes and the risk of local and regional relapse
-
Voduc D, Cheang MC, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 2010; 28:1684-1691
-
(2010)
J Clin Oncol
, vol.28
, pp. 1684-1691
-
-
Voduc, D.1
Cheang, M.C.2
Tyldesley, S.3
|